Clinical Approach to The Diagnosis of Hereditary and Acquired Neuromuscular Diseases

Authors

  • M.T. Ganieva Avicenna Tajik State Medical University, Department of Neurology, Psychiatry and Medical Psychology named after M.G. Gulyamov, Dushanbe, Tajikistan https://orcid.org/0000-0001-5865-8954
  • M.O. Isrofilov Avicenna Tajik State Medical University, Department of Neurology, Psychiatry and Medical Psychology named after M.G. Gulyamov, Dushanbe, Tajikistan https://orcid.org/0000-0002-9494-3194
  • N.A. Zaripov Avicenna Tajik State Medical University, Department of Neurology, Psychiatry and Medical Psychology named after M.G. Gulyamov, Dushanbe, Tajikistan https://orcid.org/0000-0001-5494-1218
  • M.N. Kurbonova Avicenna Tajik State Medical University, Department of Neurology, Psychiatry and Medical Psychology named after M.G. Gulyamov, Dushanbe, Tajikistan https://orcid.org/0009-0003-6063-9906

DOI:

https://doi.org/10.61788/njn.v1i27.05

Keywords:

neuromuscular diseases, hereditary phenomena, multisystem impact, diagnosis

Abstract

Progressive groups of neuromuscular diseases (NMDs), including hereditary and acquired forms, are heterogeneous pathologies affecting lower motoneurons, resulting in multisystem changes and complicating diagnosis. Diseases such as myotonic dystrophy, myasthenia gravis, and spinal muscular atrophy are characterised by a variety of symptoms and require a comprehensive approach to diagnosis, including molecular genetic development and neuroimaging. In Tajikistan, the increased mortality rate of NMDs may be related to hereditary predisposition and environmental factors, which necessitates the development of diagnostic and educational programs. The present study aims to investigate the incidence, risk factors, and diagnostic methods of NMDs in Tajikistan. The findings show that improved diagnosis and increased detection of the incidence of the disease allow to provide better medical care and improve the quality of life of patients.

References

Кушнир Г.М., Иошина Н.Н., Абибулаев С.А., Савчук Е.А. и др. Спинальные мышечные атрофии с поздним дебютом: обзор литературы и описание клинического случая // Таврический медико-биологический вестник. - 2017. - Т. 20. - №. 3-1. - С. 110-115.

Евтушенко С.К., Шаймурзин М.Р., Евтушенко И.С. Новые современные технологии в терапии нейромышечных заболеваний, направленные на замедление их прогрессирования // Международный неврологический журнал. - 2009. - №. 4. - С. 9-19.

Garg N., Park S.B., Vucic S., Yiannikas C. et al. Differentiating lower motor neuron syndromes // Journal of neurology, neurosurgery, and psychiatry, 2017, 88(6), 474-483. doi: 10.1136/jnnp-2016-313526

Ozsarlak O., Schepens E., Parizel P.M., Van Goethem J.W. et al. Hereditary neuromuscular diseases // European journal of radiology, 2001, 40(3), 184-197. doi: 10.1016/s0720-048x(01)00399-0

Nakamura K, Sekijima Y. [Genetic counseling and predictive testing for hereditary neuromuscular diseases] // Rinsho Shinkeigaku (Clinical Neurology). 2021 Sep 28;61(9):588-593. Japanese. doi: 10.5692/clinicalneurol.cn-001608

Coppedè F. Special Issue "Genetics and Epigenetics of Neuromuscular Diseases" // Genes (Basel). 2023 Jul 26;14(8):1522. doi: 10.3390/genes14081522

Saffari A, Weiler M, Hoffmann GF, Ziegler A. Gentherapien für neuromuskuläre Erkrankungen [Gene therapies for neuromuscular diseases] // Nervenarzt. 2019 Aug;90(8):809-816. German. doi: 10.1007/s00115-019-0761-z

Coppedè F. Epigenetics of neuromuscular disorders // Epigenomics. 2020 Dec;12(23):2125-2139. doi: 10.2217/epi-2020-0282

Downloads

Published

30.06.2025

How to Cite

Ganieva, M., Isrofilov, M., Zaripov, N., & Kurbonova, M. (2025). Clinical Approach to The Diagnosis of Hereditary and Acquired Neuromuscular Diseases. National Journal of Neurology, 1(27), 38–42. https://doi.org/10.61788/njn.v1i27.05

Issue

Section

Original Articles